For dogs with atopic dermatitis,CYTOPOINT® offers a full month of relief with a single in-clinic injection1, helping to improve the quality of life for dogs and their families
Targets and neutralises interleukin (IL)-31, a key itch-inducing cytokine in atopic dermatitis2
WORKS FAST AND LASTS
Begins working within 8 hours and delivers a full month of relief* from the clinical signs of atopic dermatitis1; in-clinic administration ensures compliance
Can be used in dogs of all ages, even those with concomitant disease as well as alongside many common medications1
Indication: CYTOPOINT treats clinical manifestations of atopic dermatitis in dogs.
Repeat administration monthly as needed in the individual patient.
References: 1. CYTOPOINT Summary of Product Characteristics 2. Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48-53. doi:10.1111/j.1365-3164.2012.01098.x.
The material contained within this website is intended to be viewed by practising veterinary surgeons in Ireland only. The drugs listed in this website may have different technical specifications approved in other countries.
You are now leaving the regional website to access another site in the group.
Regulatory constraints and medical practices vary across regions from market to market. Consequently, the information provided on the site in which you enter may not be suitable for use in your region.